Boothbay Fund Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-105,595
| Closed | -$483K | – | 1545 |
|
|
2025
Q1 | $483K | Buy |
105,595
+52,278
| +98% | +$239K | 0.01% | 722 |
|
|
2024
Q4 | $301K | Buy |
53,317
+3,593
| +7% | +$20.3K | 0.01% | 916 |
|
|
2024
Q3 | $241K | Buy |
+49,724
| New | +$241K | 0.01% | 1156 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1822 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1862 |
|